About Proteoz 2.5mg Injection
Redeem hope with the formidable Proteoz 2.5mg Injection, a new and popular antineoplastic solution for those facing multiple myeloma or mantle cell lymphoma. Each grand single-use glass vial contains 2.5mg Bortezomib as a lyophilized, white to off-white sterile powder, ready to be reconstituted prior to intravenous or subcutaneous administration. Prescribed exclusively by healthcare professionals and distributed across India, Proteoz stands out for its sensational proteasome inhibition activity. Store this pharmacy and hospital-exclusive medicine below 25C, protected from light, to ensure optimal efficacy throughout its 24-month shelf life.
Targeted Usage for Cancer Care
Proteoz 2.5mg Injection is specifically formulated to treat patients diagnosed with multiple myeloma and mantle cell lymphoma. Its usage is guided by physician instruction, ensuring safety and efficacy. With sterile, single-use lyophilized powder, Proteoz offers grand precision for hospital and pharmacy-supplied cancer therapies. Being a proteasome inhibitor, it sensitively inhibits enzymatic activity critical to cancer cell survival, delivering a formidable and controlled treatment pathway for eligible adults.
Sample Provision, Packaging, and Export Dynamics
Premium quality Proteoz 2.5mg Injection is available as samples for exchange or review upon drop-off request for traders and distributors. Each vial is meticulously packed in a protective glass container to maintain sterility. Recognized for its robust efficacy, this product is widely available in the Indian market and is expanding its presence through strategic exports across major pharmaceutical markets, delivering a sensational impact internationally.
FAQ's of Proteoz 2.5mg Injection:
Q: How should Proteoz 2.5mg Injection be prepared before use?
A: Proteoz 2.5mg Injection requires reconstitution using normal saline or sterile water before administration. This should be performed by a healthcare professional under sterile conditions prior to intravenous or subcutaneous injection.
Q: What are the main indications for redeeming Proteoz 2.5mg Injection?
A: Proteoz 2.5mg Injection is primarily indicated for treating multiple myeloma and mantle cell lymphoma as prescribed by a qualified physician.
Q: When is a prescription required for Proteoz 2.5mg Injection?
A: A valid prescription is always needed to access Proteoz 2.5mg Injection, as it is classified as a Prescription Only Medicine (POM) in India.
Q: Where can Proteoz 2.5mg Injection be obtained?
A: This medicine is commercially available through hospitals and pharmacies, supplied by authorized distributors, suppliers, or traders across India.
Q: What benefits does Proteoz 2.5mg Injection offer as a proteasome inhibitor?
A: As a proteasome inhibitor, Proteoz 2.5mg Injection demonstrates formidable activity in disrupting cancer cell survival mechanisms, offering targeted and effective cancer treatment options.